Changeflow GovPing Healthcare Medline Industries Class II Recall - Tego Conne...
Urgent Enforcement Removed Final

Medline Industries Class II Recall - Tego Connector Silicone Seal Defect

Favicon for changeflow.com FDA: Device Recalls Class II
Filed March 4th, 2026
Detected March 29th, 2026
Email

Summary

The FDA has initiated a Class II recall for Medline Industries' Convenience kits containing Tego Connectors (SKU DYNDC3167) due to issues with the silicone seal. The defect, including doming and tearing, can lead to an occluded fluid path, preventing proper blood product injection or withdrawal. The recall affects nationwide distribution in the US.

What changed

The FDA has issued a Class II recall for Medline Industries' Convenience kits containing Tego Connectors (SKU DYNDC3167). The affected lots have defects in the silicone seal, such as doming and tearing, which can cause an occluded fluid path. This occlusion prevents users from injecting or withdrawing blood product with a syringe, posing a risk to patient care.

Healthcare providers and facilities that have received these kits should immediately stop using them and follow Medline's instructions for product return or disposition. The recall is ongoing and affects nationwide distribution within the US. Compliance with the recall procedures is critical to mitigate patient safety risks.

What to do next

  1. Cease use of affected Medline Convenience kits containing Tego Connectors.
  2. Follow Medline Industries' specific instructions for product return or disposition.
  3. Document compliance with recall procedures.

Source document (simplified)

Medline Industries, LP

Device Recalls (Class II)

← All Device Recalls (Class II) Class II Z-1468-2026 · 20260304 · Ongoing

Product

Convenience kits containing Tego Connectors Medline DIALYSIS DRSNG CHNG SKU DYNDC3167

Reason for Recall

Affected lots may exhibit issues with the silicone seal on Tego Connectors included in kits. Issues include silicone seal doming and silicone seal tearing. These issues may result in an occluded fluid path identified by the inability of the user to inject or withdraw blood product with a syringe....

Distribution

US Nationwide distribution.

Source: openFDA Enforcement API

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
FDA
Filed
March 4th, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
Z-1468-2026

Who this affects

Applies to
Healthcare providers Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical Device Recalls Product Safety
Threshold
Class II
Geographic scope
United States US

Taxonomy

Primary area
Product Safety
Operational domain
Compliance
Topics
Medical Devices Healthcare

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when FDA: Device Recalls Class II publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.